This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Global Med Technologies(R) Licenses Laboratory Solution To Historic European Hospital

DENVER, Dec. 17 /PRNewswire-FirstCall/ -- Global Med Technologies®, Inc. ("Global Med" or the "Company") (OTC Bulletin Board: GLOB), an international healthcare information technology company, today announced that its Inlog, SA subsidiary has licensed its EdgeLabâ„¢ Laboratory Information Management Software (Marketed as "Labo Serveur" in France) to the centuries-old Centre Hospitalier de Verdun in Verdun, France.  Terms of the agreement were not disclosed.


EdgeLab is a leading laboratory information management system in Europe used by more than 150 licensed laboratories.  EdgeLab can be interfaced to more than 1,000 analyzers and interchanges data with all major hospital healthcare software applications.  Its comprehensive range of laboratory functionality can be easily configured to meet the business needs of large, diverse, multi-site hospital laboratories, as well as small, single-site hospitals.  The Verdun Hospital Laboratory will use EdgeLab to process over 350 patient files per day.  The system will be interfaced to six analyzers and one instrument middleware product.

Will Willman, Global Med's Sr. Vice President of Sales and Marketing EU/ME/ Asia, stated, "We are very pleased that the historic Centre Hospitalier de Verdun has selected Inlog's EdgeLab solution to upgrade their laboratory software.  Verdun's decision was a result of the excellent references that our software received from the Inlog customers that Verdun contacted, the full range of features the software offers, the integrated SapaNet (El Dorado Control) quality management software, and the ability to interface to our EdgeTrack transfusion management software (not for sale in the U.S.) on the same database."

About Centre Hospitalier de Verdun

The Verdun Hospitals have a rare and fascinating history.  Founded in the 7th century, the first written evidence of a care facility near the current location was in 1093.  The hospital has evolved through the centuries: the thirteenth century saw a name change to Sainte-Catherine; in 1570 a general hospital was formed; during the French Revolution the organization Hospices Civils de Verdun (Sainte-Catherine and Saint-Nicolas) was created; Sainte-Catherine was partially destroyed during WWI, and then repaired; St. Nicolas was used as a military hospital during WWII.  Between World War II and 2007, Verdun hospitals expanded to four separate facilities including Desandrouins and Saint Joseph.  At almost 1,000 beds in three different sites, Verdun handles about 25,000 emergencies per year.  Nearly 1,800 people work at the hospital including more than 170 physicians.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
GLOB $21.07 0.00%
AAPL $123.25 0.00%
FB $83.30 0.00%
GOOG $548.34 0.00%
TSLA $185.00 0.00%


DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs